BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 144-152

  Susperregui, Antonio R G ^a   Viñals, Francesc ^a   Ho, Patricia W M ^b   Gillespie, Matthew T ^b   Martin, T John ^b   Ventura, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; BONE MORPHOGENETIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 14; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BONE; BONE DEVELOPMENT; CELL LINE; CYTOLOGY; FIBROBLAST; GENETICS; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; FIBROBLASTS; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 14; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PARATHYROID HORMONE-RELATED PROTEIN; PROMOTER REGIONS (GENETICS); RANK LIGAND; RECEPTOR, PARATHYROID HORMONE, TYPE 1; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 44449176128     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21389     Document Type: Article

References (52)

1. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economises AN, Stahl N, Jilka RL, Manolagas SC. 2000. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin. J Bone Miner Res 15:663-673.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
3. Brugger SM, Merrill AE, Torres-Vazquez J, Wu N, Ting MC, Cho JY, Dobias SL, Yi SE, Lyons K, Bell JR, Arora K, Warrior R, Maxson R. 2004. A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos. Development 131:5153-5165.
4. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235.
5. Chan GK, Miao D, Deckelbaum R, Bolivar I, Karaplis A, Goltzman D. 2003. Parathyroid hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T 1/2 mesenchymal cells. Endocrinology 144:5511-5520.
6. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22:233-241.
7. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, Nacamuli RP, Contag CH, Wu B, Longaker MT. 2005. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 11:645-658.
8. Du P, Ye Y, Seitz PK, Bi LG, Li H, Wang C, Simmons DJ, Cooper CW. 2000. Endogenous parathyroid hormone-related peptide enhances proliferation and inhibits differentiation in the osteoblast-like cell line ROS 17/2. 8. Bone 26:429-136.
9. Ghosh-Choudhury N, Singha PK, Woodruff K, St Clair P, Bsoul S, Werner SL, Choudhury GG. 2006. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem 281:20160-20170.
10. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ. 1991. Parathyroid hormone-related protein: Elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73:1309-1315.
11. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18:2060-2068.
12. Hofbauer LC, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. 1998. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 250:776-781.
13. Hollnagel A, Ahrens M, Gross G. 1997. Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T 1/2). J Bone Miner Res 12:1993-2004.
14. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
15. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA. 2004. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235-244.
16. Huang MS, Morony S, Lu J, Zhang Z, Bezouglaia O, Tseng W, Tetradis S, Demer LL, Tintut Y. 2007. Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts. J Biol Chem 282:21237-21243.
17. Irie K, Alpaslan C, Takahashi K, Kondo Y, Izumi N, Sakakura Y, Tsuruga E, Nakajima T, Ejiri S, Ozawa H, Yajima T. 2003. Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2). J Bone Miner Metab 21:363-369.
18. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A. 1997. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970.
19. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T. 1996. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384-1393.
20. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. 2001. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142:3656-3662.
21. Jiang D, Franceschi RT, Boules H, Xiao G. 2004. Parathyroid hormone induction of the osteocalcin gene. Requirement for an osteoblast-specific element I sequence in the promoter and involvement of multiple-signaling pathways. J Biol Chem 279:5329-5337.
22. Ju W, Hoffmann A, Verschueren K, Tylzanowski P, Kaps C, Gross G, Huylebroeck D. 2000. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res 15:1889-1899.
23. Kartsogiannis V, Moseley J, McKelvie B, Chou ST, Hards DK, Ng KW, Martin TJ, Zhou H. 1997. Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model. Bone 21:385-392.
24. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
25. Kobayashi T, Kronenberg H. 2005. Minireview: Transcriptional regulation in development of bone. Endocrinology 146:1012-1017.
26. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Runx2 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
27. Krane SM. 2005. Identifying genes that regulate bone remodeling as potential therapeutic targets. J Exp Med 201:841-843.
28. Kronenberg HM. 2006. PTHrP and skeletal development. Ann NY Acad Sci 1068:1-13.
29. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LH, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM. 1996. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666.
30. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. 2000. Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2 C12. Mol Cell Biol 20:8783-8792.
31. Li TF, Dong Y, Ionescu AM, Rosier RN, Zuscik MJ, Schwarz EM, O'Keefe RJ, Drissi H. 2004. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res 10:128-136.
32. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F. 2002. Direct binding of SmadI and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of 1d1 gene. J Biol Chem 277:3176-3185.
33. Martin TJ, Sims NA. 2005. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76-81.
34. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev 19:2783-2810.
35. McCauley LK, Koh AJ, Beecher CA, Cui Y, Decker JD, Franceschi RT. 1995. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells. J Bone Miner Res 10:1243-1255.
36. Miyazono K, Maeda S, Imamura T. 200S. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16:251-263.
37. Moustakas A, Heldin CH. 2005. Non-Smad TGF-beta signals. J Cell Sci 118:3573-3584.
38. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
39. Nöth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
40. Quinn JM, Gillespie MT. 2005. Modulation of osteoclast formation. Biochem Biophys Res Commun 328:739-745.
41. Ramsauer K, Sadzak I, Porras A, Pilz A, Nebreda AR, Decker T, Kovarik P. 2002. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 99:12859-12864.
42. Roodman GD. 2006. Regulation of osteoclast differentiation. Ann NY Acad Sci 1068:100-109.
43. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
44. Suda N, Gillespie MT, Traianedes K, Zhou H, Ho PW, Hards DK, Allan EH, Martin TJ, Moseley JM. 1996. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol 166:94-104.
45. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. 2002. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
46. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE. 2000. The osteoblast-specific transcription factor Runx2 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275:25163-25172.
47. Tintut Y, Parhami F, Le V, Karsenty G, Demer LL. 1999. Inhibition of osteoblast-specific transcription factor Runx2 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J Biol Chem 274:28875-28879.
48. van der Horst G, Farih-Sips H, Lowik CW, Karperien M. 2005. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J Bone Miner Res 20:2233-2244.
49. Vinals F, Lopez-Rovira T, Rosa JL, Ventura F. 2002. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. FEBS Lett 510:99-104.
50. Wan M, Cao X. 2005. BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651-657.
51. Wan M, Shi X, Feng X, Cao X. 2001. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. J Biol Chem 276:10119-10125.
52. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. 1996. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93:10240-10245.